Tardive dyskinesia syndrome in neuroleptic therapy. General considerations and clinical observations on forty cases investigated.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000188:drug therapy; D004409:Dyskinesia, Drug-Induced / Q000209:etiology*; D005260:Female; D006220:Haloperidol / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D010640:Phenothiazines; D012559:Schizophrenia / Q000188:drug therapy
D014150:Antipsychotic Agents; D010640:Phenothiazines; D006220:Haloperidol